Rallis India soars on planning to merge Metahelix Life Sciences with itself

Rallis India is currently trading at Rs. 172.10, up by 3.00 points or 1.77% from its previous closing of Rs. 169.10 on the BSE.

The scrip opened at Rs. 171.90 and has touched a high and low of Rs. 172.85 and Rs. 167.30 respectively. So far 5957 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 282.00 on 18-Jan-2018 and a 52 week low of Rs. 159.55 on 03-Dec-2018.

Last one week high and low of the scrip stood at Rs. 172.85 and Rs. 166.65 respectively. The current market cap of the company is Rs. 3346.81 crore.

The promoters holding in the company stood at 50.09%, while Institutions and Non-Institutions held 23.95% and 25.95% respectively.

Rallis India is planning to merge its wholly owned subsidiary -- Metahelix Life Sciences with the company. The Board of Directors of the Company at its meeting to be held on January 17, 2019 to consider the same.

Rallis India mainly deals in Agri Business and has emerged as one of the leaders in the Indian Agrochemical Industry. The company is also in the Institutional business providing technical and bulk of various molecules to leading companies like Bayer, Syngenta, Excel, UPL, Gharda, Cheminova etc.